naringenin has been researched along with Polycystic Ovarian Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Xu, W | 1 |
| An, T; Bao, XL; Gao, L; Han, BS; Hu, YY; Jiang, GJ; Lian, J; Lv, BH; Wang, TY; Wu, YX; Yang, XY | 1 |
| Bader, GN; Gupta, RK; Gupta, S; Jha, RK; Kawale, A; Rashid, R; Sarkar, S; Singh, A; Tripathi, R | 1 |
| Geng, X; Li, Y; Song, Y; Tan, L; Wan, L; Wang, M; Xiang, Y; Yu, G | 1 |
| Hong, K; Hong, Y; Tan, Y; Yin, Y; Zhou, H | 1 |
5 other study(ies) available for naringenin and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Naringenin and morin reduces insulin resistance and endometrial hyperplasia in the rat model of polycystic ovarian syndrome through enhancement of inflammation and autophagic apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cell Line, Tumor; Cytokines; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Flavanones; Flavonoids; Humans; Inflammation; Insulin Resistance; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Polycystic Ovary Syndrome; Rats; Signal Transduction | 2022 |
Naringenin regulates gut microbiota and SIRT1/ PGC-1ɑ signaling pathway in rats with letrozole-induced polycystic ovary syndrome.
Topics: Animals; Body Weight; Claudin-1; Female; Flavanones; Gastrointestinal Microbiome; Hormones; Humans; Letrozole; Occludin; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1 | 2022 |
Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the Sprague Dawley rats.
Topics: Androgens; Animals; Disease Models, Animal; Female; Follicular Cyst; Humans; Letrozole; Metformin; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley | 2023 |
Naringenin alleviates the excessive lipid deposition of polycystic ovary syndrome rats and insulin-resistant adipocytes by promoting PKGIα.
Topics: Adipocytes; Animals; Cyclic GMP-Dependent Protein Kinase Type I; Female; Glucose; Humans; Insulin; Insulin Resistance; Lipids; Polycystic Ovary Syndrome; Rats | 2023 |
The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.
Topics: Animals; Antioxidants; Catalase; Disease Models, Animal; Estradiol; Female; Flavanones; Glutathione Peroxidase; Letrozole; Ovary; Oxidative Stress; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Testosterone | 2019 |